Gapping up
In reaction to earnings/guidance:
- DOYU +14.8%, CAL +10.5% (also boosts its share buyback authorization by 7 mln shares), JBL +9.3%, FF +5.3%, UUUU +3.7%, SRG +2.6%, HOLI +2.2%
Select Chinese ADRs showing strength:
- PDD +34.1%, LI +22.1%, JD +21.4%, XPEV +19.6%, BABA +19.3%, NIO +18.6%, HUYA +17.6%, NTES +17.2%, WB +15.4%, BIDU +14%, ASHR +9.1%
Other news:
- BILI +31.2% (to pursue voluntary conversion to dual-primary listing on the main board of The Stock Exchange of Hong Kong)
- LX +18.8% (authorizes $50 mln share repurchase program)
- FFIE +13.1% (receives Nasdaq acceptance of plan to regain listing compliance)
- MAXN +9.9% (announces multi-year order for 315 MW of Performance line solar panels)
- AVAV +8.5% (report that President Biden could provide Ukraine with Switchblades drones)
- IOVA +7.9% (FDA allows IND to proceed for IOV-4001)
- BTBT +6.3% (reports Bitcoin production and mining operations update for Q4)
- BIIB +4.8% (Long-term phase 3 data show ADUHELM continues to reduce underlying pathologies of alzheimer's disease in patients treated for more than two years) BNTX +4.6% (BioNTech and Pfizer (PFE) submit for Emergency Use Authorization of an additional booster dose of their COVID-19 vaccine for older adults)
- ADAG +4.3% (receives FDA clearance to proceed with Phase 1b/2 Trial of Anti-CTLA-4 ADG126 SAFEbody in combination therapy with Anti-PD-1 antibody pembrolizumab)
- VTRS +3.2% (confirms FDA approval for generic Symbicort)
- SPOT +2.6% (announces partnership with FC Barcelona to bring music and football together)
- FNF +1.8% (announces a planned transaction to distribute 15% ownership of F&G to FNF shareholders; F&G shares to be publicly listed through a partial spin-off)
- HRZN +1.3% (leads $10 mln venture loan facility to Aerobiotix)
- HMC +1% (plans to spend $1.38 bln to upgrade an Ontario manufacturing plant, according to The Globe and Mail)